Head of Development
Dr. Kristell Chatalic studied organic chemistry at the Engineering School of Chemistry, Polymers and Material Science (ECPM) in Strasbourg (France). Kristell subsequently started a PhD study on a project at the interface of radiochemistry, molecular imaging and radionuclide therapy at the Erasmus MC (Rotterdam). After her PhD graduation in 2016, Kristell gained close to 5 years of experience in development of (radio)pharmaceutical products in GMP-qualified laboratories at Radboud Translational Medicine, Ardena and Thermo Fisher. She has experience in process and quality control method development for various (radio)pharmaceutical products. Currently, Kristell is working as Head of Development at Radboud Translational Medicine.